Chimeric Cerebral Organoids with NFIB/SOX9-Induced Astrocytes for Alzheimer's Disease Modeling
Source Huang et al., 2022 · State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences · 10.1038/s41392-022-01006-x
Abstract
This protocol describes the generation of chimeric human cerebral organoids (chCOs) that incorporate induced astrocytes via lentiviral expression of NFIB and SOX9 transcription factors. The resulting organoids model Alzheimer's disease pathology by combining neurons and astrocytes with different APOE genotypes (APOE3 or APOE4), enabling assessment of the differential roles of astrocytic and neuronal APOE4 in tau and amyloid-beta pathology.
Protocol overview
17 steps across 5 phases
- 1 Maintain hPSC culture
- 2 Confirm cell viability and mycoplasma status
- 1 Dissociate and transduce hPSCs with lentivirus
- 2 Plate mixed cells into EB formation
- 3 Culture EBs in EB Formation Medium
- 1 Transfer EBs to induction phase
- 2 Culture in Induction Medium
- 3 Embed organoids in Matrigel
- 4 Transfer to Expansion Medium
- 5 Transfer to Maturation Medium and orbital shaker
- 1 Perform medium changes
- 2 Monitor astrocyte induction (optional milestones)
- 3 Assess neuronal maturation at day 60 (optional)
- 1 Prepare organoids for immunofluorescence staining
- 2 Embed organoids in OCT and cryosection
- 3 Prepare organoids for single-cell isolation
- 4 Prepare supernatant for biochemical assays
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Huang et al., 2022. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol